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 The synthesis of natural products is a growing area of research within the 
field of chemistry. Compounds are extracted from sources such as fungi, plants, 
algae, and other natural sources. The compounds that are biologically active 
often need to be synthesized in the laboratory due to the fact that the natural 
resources only contain scant amounts of the active compound.  
 In this research, kinetic resolution, a form of asymmetric synthesis, is used 
in conjunction with Brønsted acid catalysts to form enantioenriched small 
molecules that can later be used in the synthesis of natural products. The 
Petersen lab chose to focus on substituted γ-hydroxy tert-butyl esters. The small 
molecule was lactonized via a Brønsted acid catalyzed kinetic resolution yielding 
enantioenriched starting material. In kinetic resolution, the maximum amount of 
material that can be achieved is 50% with an enantiomeric excess of 100%. 
 Initial optimization was conducted on α-substituted γ-hydroxy tert-butyl 
esters which showed that R-TRIP was the best catalyst in the kinetic resolution. 
γ-Substituted and disubstituted γ-hydroxy tert-butyl esters were tested with the 
syn-α,γ-dimethyl substrate showing the highest selectivity (s = 15.6). Cyclic 
hydroxy esters are currently being tested.   
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CHAPTER I 
 
BACKGROUND AND SIGNIFICANCE 
 
 
Asymmetric syntheses have gained interest over the last few decades as 
pharmaceutical companies begin the switch to nonracemic medications. This is 
due in part to the extended patent life that companies can obtain by separating 
enantiomers of an already known racemic compound; but many drugs will have 
one active stereoisomer and while the other is inactive or harmful. In the case of 
2-(6-methoxynaphthalen-2-yl)propanoic acid (figure 1), the S-enantiomer is 
known as Naproxen (1), a medication used to relieve pain, fever, and 
inflammation brought on by arthritis. 
 
 
 
Figure 1. The R- and S-Enantiomers of Naproxen 
 
 The R-enantiomer (2) is much less potent than the S-enantiomer.1 The 
purpose of an asymmetric synthesis is to prepare stereochemically-enriched 
compounds efficiently. This chapter will touch on three key points of asymmetric 
synthesis: kinetic resolution, chiral Brønsted acid catalysts, and small-molecule 
synthesis. 
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1.1 Kinetic Resolution 
Asymmetric syntheses2 fall into three broad categories; chiral pool, 
enantioselective synthesis, and resolution. A chiral pool asymmetric synthesis is 
one in which the starting material is an enantiopure natural product.  In the 
synthesis developed by Yan and group3 (figure 2), commercially available L-
tartaric acid (3) served as the chiral pool to yield unnatural pinitols, shikimic 
acids, and their analogues. 
 
 
 
Figure 2. Retrosynthesis of Pinitol and Shikimic Acid via L-Tartaric Acid 
 
 
An enantioselective synthesis uses achiral precursors and the reaction of 
these compounds with chiral reagents or catalysts. In the synthesis developed by 
Trost and Miege4, syn β-hydroxy α-amino esters can be formed 
enantioselectively through the asymmetric aldol reaction of glycine Schiff bases 
and aldehydes using a zinc-ProPhenol-catalyst (8). 
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Figure 3. Synthesis of Syn β-Hydroxy α-Amino Esters 
 
 
 The final category of asymmetric syntheses is resolution. In a resolution, a 
racemic mixture is differentiated through chemical or physical means; the 
resulting product(s) can then be separated as enantiopure compounds. 
Resolutions fall into three classes; classical resolution, chiral chromatography, 
and kinetic resolution. Classical chiral resolution involves the use of a 
stoichiometric amount of a chiral resolving agent. In the Eli Lilly  synthesis of 
duloxetine5 (figure 4), the starting material, (±)-12, is first resolved using (S)-
mandelic acid.  
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Figure 4. Eli Lilly's Synthesis of Duloxetine 
 
 (S)-Mandelic acid is reacted with compound 12 to yield salt 13 and 
enantioenriched (R)-12. Compound 13 is then reacted with base to yield the 
other enantiomer, (S)-12, which can then be used to synthesize duloxetine (14). 
This approach is most useful for amines and carboxylic acids as salt formation is 
straightforward. 
 Chiral chromatography relies on the use of a chiral stationary phase to 
resolve enantiomers in a mobile phase. While chiral chromatography is 
frequently used for analysis, chiral chromatography as part of a synthesis is not 
ideal. This is due to the large solvent volumes, long separation times, and high 
costs of the chiral stationary phases.  
The final class of resolution we will examine is kinetic resolution. Kinetic 
resolutions distinguish the enantiomers of a racemic mixture with the use of a 
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chiral catalyst or reagent. The chiral catalyst or reagent promotes selective 
reaction of one enantiomer over the other yielding enantioenriched product as 
well as enantioenriched, unreacted starting material.  
A kinetic resolution (figure 5) takes advantage of the different rates of 
reaction of two enantiomers in a racemic mixture with a chiral reagent or catalyst. 
 
 
 
Figure 5. Relative Rates of Reaction 
 
 
  As seen in figure 5, the relative rates of reaction for the substrate 
enantiomers, SR and SS, is dictated by the difference in the activation energies of 
each enantiomer of the rate limiting step (∆∆G‡). Due to the difference of rates, 
up to a 50% yield of either the new product or the recovered starting material can 
be obtained with up to 100% enantiomeric excess (ee). The ee of the substrate 
or product changes as a function of conversion; as seen in figure 6, the 
substrate’s ee will increase as conversion increases.  
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Figure 6. Conversion vs %ee 
 
 
 Another facet of kinetic resolution is the selectivity factor s. As seen in 
table 1, a set of representative values6 of krel and ∆∆G
‡ show the extent of 
conversion needed to achieve 90, 98, and 99% ee of recovered unreacted 
starting material. The krel or s (equation in figure 6) can help determine how 
selective a kinetic resolution may be and whether it is a valuable reaction. Due to 
the changes in enantiomeric excess as conversion increases, s factors can 
provide more consistent information.  
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Table 1. Representative krel with % Conversion Required for High 
Enantiomeric Excess 
 
  Conversion (%) required to achieve: 
krel 
∆∆G‡ 
(kcal/mol) 
90% ee 95% ee 99% ee 
1.5 0.24 99.9 99.99 >99.999 
2 0.41 97.2 99.5 >99.7 
5 0.95 74.8 84.0 >86.6 
10 1.35 62.1 69.7 >72.1 
50 2.31 50.4 54.0 >54.9 
100 2.72 48.9 51.8 >52.4 
500 3.66 47.7 50.0 >50.3 
  
 Kinetic resolutions have been used in multiple experimental situations 
including but not limited to: acylative/deacylative resolutions, oxidative kinetic 
resolutions, reductive kinetic resolutions, organometallic kinetic resolutions, and 
kinetic resolution of epoxides via nucleophilic ring opening. The first kinetic 
resolution was done by Marckwald and McKenzie (figure 7)7 when they observed 
enantioselective esterification by heating racemic mandelic acid (15) with ()-
menthol (16).  
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Figure 7. The First Kinetic Resolutions 
 
 They were able to recover a small amount of L-mandelic acid (18) after 
recrystallization. The first published kinetic resolution was done by Dakin (figure 
7)8 in 1904 using crude pig liver lipase to resolve racemic ethyl mandelate (19) 
through hydrolysis. 
 1.2 Brønsted Acid Catalysts 
  
Carbonyl activation plays an important role in organic synthesis. Chiral 
acids have, in recent years9, become a focus of asymmetric syntheses and 
Brønsted acid catalysts (figure 8) have been used in achiral synthesis as 
carbonyl activators.  
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Figure 8. Chiral Brønsted Acids 
 
 New chiral diols and hydrogen bond donors were developed that 
displayed the ability to induce high diastereo- and enantioselectivity. The 
catalysts developed were originally used in Diels-Alder and Mukaiyama aldol 
reactions (figure 9). Under these conditions, the activated carbonyl reacted with 
very strong nucleophiles and only required slightly acidic catalysts.  
 
 
 
Figure 9. Chiral Diols Used in Synthesis 
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 In 2004, axially chiral 1,1’-bi-2-naphthol (BINOL) phosphoric acid derived 
catalysts where developed by the Akiyama and Terada groups10. These catalysts 
(figure 10) were primarily used in reactions in which the catalyst activated 
reactive electrophiles such as aldimines, ketimines, and aziridines.  
 
 
 
Figure 10. Chiral BINOL Phosphoric Acid Catalysts 
 
 
 A few years later it was found that substrates with less basic functionalities 
were able to be activated by these BINOL derived phosphoric acid catalysts. 
Yamamoto and group11 uncovered more acidic chiral Brønsted acids based on 
the BINOL phosphoric acid catalyst. These catalysts (figure 11) have replaced 
the hydroxyl group with a triflylamide moiety. The strong electron withdrawing 
character of the new substituent significantly increased the acidity of the catalyst.  
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Figure 11. N-Triflylphosphoramides 
 
 
 The above catalysts have several features that are important to activation 
(figure 12).  
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Figure 12. Features of Chiral BINOL Phosphoric Acid Catalysts 
 
 
 The BINOL backbone is the core structure of the catalyst. It is axially chiral 
and rigid. The core structure is modified by substituents placed at the 3 and 3’ 
positions. These substituents add steric hindrance and electronic effects to the 
catalyst. The substituents shield the active site to allow for specificity. The 
catalyst also possesses an acidic proton and a phosphoryl oxygen that can act 
as a hydrogen bond acceptor. The catalysts activate the substrate by one of two 
modes (figure 12).  
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Figure 13. Carbonyl Activation 
 
 
 The first is through a direct hydrogen bonding event between the substrate 
carbonyl oxygen and the acidic proton of the catalyst. The second mode is 
through a contact ion pair where the carbonyl oxygen of the substrate takes the 
acidic proton from the catalyst. The second mode is less likely and it has been 
predicted that activation is most likely a combination of the two modes. The pKa 
difference between the catalyst and the substrate determines which activation 
mode is the most populated in equilibrium. 
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1.3 Small Molecule Synthesis 
 
 
 
 
Figure 14. Natural Products Synthesized via Small Molecules 
 
 
 An important facet of organic synthesis is the development of pathways to 
small molecules. These small molecules, especially those that are 
stereochemically enriched, can be used in the production of larger, more 
complex, chiral molecules. Many reviews have been written on the use of small 
14 
 
molecules in enantioselective syntheses. In 2004, a review was written by Tom 
Pettus12 detailing the use of four cyclohexadienone ketals and quinols (figure 14) 
in enantioselective syntheses of natural products.  
 
 
 
Figure 15. Cyclohexadienone Building Blocks 
 
 
 Compounds similar to 42 have been used in the synthesis of khellinone13 
(33, figure  14), CP-263,41114, calicheamicinone15, ryanodol16, a derivative of 
forsythide17, and colchicines18. The ketal 43 has been used in the synthesis of 
five natural product families: manumycins (34, figure 14), huperizes, 
torreyanoids, diepoxins, and illudines19. Compound 44-like substrates have been 
used in the synthesis of calicheamicinone20, ovalicin21 (35, figure 14), aerothionin 
and homoaerothionin22, trichodimerol23, and tricycloillicinone24. P-quinol 
derivatives (45) have been used in the synthesis of griseofulvinoids, futoquinoids, 
sorbicillinoids, and ananorosinoids25. 
15 
 
 A review of β-lactams as small molecule building blocks was published in 
200726. Since the discovery of penicillin, antibiotics with the β-lactam skeletal 
structure have been the subject of discussion and interest. -Lactams can be 
used in the synthesis of mono-, bi-, and polycyclic 3 to 6 membered heterocycles 
as well as macrocyclic heterocycles27 (figure 15).  
 
 
 
Figure 16. β-Lactam Building Block 
 
 2-Azetidinone (46) is the core of the β-lactam structure. It has four easy-
to-break bonds resulting from bond and angle strain. The strained bonds and 
unique bond angles have allowed this structure to become a synthetically useful 
building block. 
 A more recent review28 compiled by Reddy and coworkers identifies the 
recent boost in the use of δ-hydroxy α,β-unsaturated aldehydes. The many 
16 
 
functionalities and ability to selectively manipulate each position have led this 
compound to be highly studied. δ-Hydroxy α,β-unsaturated aldehydes, further 
known as Perlin aldehydes, are compounds derived from glycal, a term for cyclic 
enol ethers that contain a double bond between carbons 1 and 2. Perlin 
aldehydes have been used in stereoselective synthesis of various cyclic and 
acyclic building blocks as well as naturally occurring compounds such as sex 
pheromones, cofactors, sphingosine derivatives, metabolites, (-)-cassine (40, 
figure 14), piperidine alkaloids, phytotoxins, and nucleosides.  
1.4 Conclusion 
 
  Natural products are continuously tested for biological activity. 
Compounds that show activity are of interest to scientists; however, due to the 
often small amount produced by the natural source, synthetic chemists have a 
considerable need to develop new methodologies to prepare these compounds 
in sufficient quantities. One of the many ways to prepare natural products 
synthetically is through small molecules. Small molecules can be perfect 
precursors with set chirality as well as easily manipulated functionalities. First, 
however, the small molecules must be made. The next two chapters will discuss 
how kinetic resolution and Brønsted acid catalysts can be used to yield 
enantiopure small molecules that can be used in the synthesis of natural 
products.
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CHAPTER II 
 
FACILE SYNTHESIS OF ENANTIOENRICHED α-SUBSTITUTED γ-HYDROXY 
TERT-BUTYL ESTERS 
 
2.1 Background 
 
The lactone functional group is becoming of increasing importance to the 
medicinal field. It is a common motif in various biologically active compounds. 
Most lactone functional groups contain a chiral center whose configuration must 
be set properly for bioactivity. Current asymmetric synthetic strategies involve 
expensive chiral auxiliaries to install chiral centers1, inclusion-type reactions that 
involve crystals and microbes2, and installing stereocenters early in the 
synthesis3. The problem with installing stereocenters early on is that one has to 
take into consideration how certain reactions later in the synthesis will change 
the stereocenter. There is a need for asymmetric syntheses that do not involve 
too many expensive reagents, reagents that cannot be removed easily, or 
excessive steps.  
 
 
 
Figure 17. Skeletal Structure of the Hydroxy Ester Substrate 
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Enantioenriched hydroxy esters of the form 56 (figure 16) contain two 
distinct functionalities that can be easily manipulated (shown in red and orange). 
This leads compounds such as 56 to be versatile building blocks. Previous 
syntheses of these molecules are virtually nonexistent. This is likely due to the 
tendency of non-bulky esters to lactonize or epimerize. Two examples are a 
hydroboration/oxidation (figure 18) of an α-substituted allylic ester prepared by an 
asymmetric copper catalyzed SN2’-addition
4 and an organocatalyzed Friedel-
Crafts alkylation of an α,β-unsaturated ester/aldehyde (figure 19) followed by 
reduction5.  
 
 
Figure 18. Copper-Catalyzed SN2 Addition 
 
 
 
Figure 19. Friedal-Crafts Alkylation 
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 Stabilization of these hydroxy esters through the use of a bulky ester and 
an enantioselective synthesis will allow the wide spread use of these building 
blocks in the construction of important biologically active molecules. 
The strategy for the preparation of these versatile building blocks takes 
advantage of the different rates of reaction of both enantiomers in the presence 
of a chiral Brønsted acid catalyst (Figure 20).  
 
 
 
Figure 20. Chiral Brønsted Acid Catalysts 
 
 
 By using bulky esters, the instability of the substrates is reduced allowing 
for slower reaction times and decreased reactivity such that the reaction will only 
happen in the presence of a strongly activating acid catalyst (figure 21). The two 
enantiomers can then be separated via the selective lactonization of one 
enantiomer over the other.  
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Figure 21. Kinetic Resolution of a Hydroxy Ester with a Chiral Catalyst 
 
 
2.2 Results and Discussion 
 
 Initial optimization of the kinetic resolution was completed by Petersen 
group lab member, Ghassan Qabaja, using α-methyl hydroxy tert-butyl ester 73a 
(Table 2).   
 
Table 2. Initial Optimization 
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 The hydroxy ester was cooled to 5 ˚C in dichloromethane and treated with 
a variety of chiral Brønsted acid catalysts. TADDOL and thiourea catalysts (table 
2, entries 1 and 2) were unable to drive the reaction towards product. Camphor 
sulfonic acid (table 2, entry 3) and unsubstituted BINOL phosphoric acid (table 2, 
entry 4) were able to induce lactonization; however, no enantiomeric excess (ee) 
of either recovered starting material or lactone product was achieved. When 3,3’-
substituted BINOL phosphoric acid catalysts (table 2, entries 5-7) were used, 
enantioenrichment of both the starting material and product was seen; with the 
triisopropyl phenyl catalyst showing the most selectivity. Catalyst 72 pushed the 
conversion to 40% yielding lactone 74a with a 68% ee and recovered hydroxy 
ester 73a with 57% ee giving a selectivity factor of 25.  
 A limited solvent screen (table 2, entries 8-10) was performed using both 
protic and aprotic solvents. Polar solvents such as tetrahydrofuran (THF) and 
diethyl ether (Et2O) were ineffective in the lactonization. This is likely due to the 
interruption of hydrogen bonding between the catalyst and the substrate. Non-
polar solvents dichloromethane, toluene, and hexanes allowed for conversion to 
product. A small temperature screen was carried out using toluene as the 
solvent. It was seen that temperature only affects the reaction time where low 
temperatures significantly increase reaction time. These optimized conditions 
allowed for consistent selectivity factors of ~20 with the test substrate 73a. 
 With optimized conditions in hand, a substrate scope was developed and 
completed (Table 3).  The first substrates tested were those with different ester 
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functionalities. The smaller isopropyl ester 73b (table 3, entry 1) showed severely 
reduced selectivity and reaction time. The bulkier 2,4-dimethyl-3-pentyl ester 73c 
(table 3, entry 2) was exorbitantly slow and required heat to push conversion 
while showing low selectivity. This research revealed that the tert-butyl ester was 
the “Goldilocks” of the esters tested.  
 
Table 3. Substrate Scope 
 
 
 
 To form the ester substrates, commercially available α-methyl-γ-
butyrolactone (75) was opened with benzyl bromide (BnBr) and potassium 
hydroxide (KOH) in toluene at reflux. The intermediate was then saponified with 
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KOH in methanol:water (MeOH:H2O, 1:0.5) at reflux to form carboxylic acid 76 
(figure 22). 
 
 
 
Figure 22. Opening of α-Methyl-γ-Butyrolactone 
 
 
 Acid/ether 76 was then esterified with a variety of alcohols. Thionyl 
chloride and isopropyl alcohol were reacted with 76 to form ester/ether 77. 
Thionyl chloride is used to make the hydroxyl group a better leaving group 
allowing for esterification by isopropyl alcohol (figure 23). Hydrogenolysis was 
then implemented with palladium hydroxide on carbon and gaseous hydrogen on 
the intermediate 77 to form ester 73b; no yield was obtained on this reaction. 
 
 
 
Figure 23. Formation of Intermediate 77 
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 This ester performed poorly during lactonization with the chiral catalyst 
likely due to the ease with which the ester lactonizes in the absence of a catalyst. 
The next ester tested was a bulky ester. The first method for preparation 
attempted was a Steglich esterification6 of diphenylcarbinol and 76 using N,N’-
dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in 
dichloromethane (figure 24) to form the ester/ether 84. Not surprisingly, upon 
hydrogenolysis, it was noticed that the diphenylcarbinol functionality was labile 
and would reduce to the carboxylic acid rather than the reduction to the hydroxy 
ester with removal of the benzyl group. 
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Figure 24. Formation of Intermediate 84 
 
 Another bulky alcohol was chosen for the esterification of 76 that would be 
orthogonal to the benzyl ether protecting group. Thus, diisopropylcarbinol was 
chosen and used in a Steglich esterification (figure 25). The benzyl group of 
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ester/ether 85 was removed via hydrogenolysis with palladium hydroxide on 
carbon and gaseous hydrogen to afford hydroxy ester 73c in a quantitative yield.  
 
 
Figure 25. Formation of Intermediate 85 
 
 Petersen group lab members found that hydroxy esters with bulky α-
substituents (table 3, entries 3 and 4, isopropyl 73d and phenyl 73e) were poor 
substrates in the resolution. Hydroxy esters with small to moderately-sized 
substituents (table 3, entries 5 and 6, ethyl 73f and allyl 73g) proceeded through 
the resolution with adequate to good selectivities. The α-allyl substrate yielded 
recovered starting material with good selectivity. The α,α-disubstituted hydroxy 
ester yielded good selectivity producing a challenging all-carbon quaternary 
center (table 3, entry 7, 73h).  
 Another facet of this research is the desymmetrization of prochiral 
substrates (figure 26) developed by Jennifer Wilent, a graduate student in the 
Petersen lab. In this set of experiments, a prochiral diester is reacted with a chiral 
catalyst to yield enantiopure lactone. 
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Figure 26. Desymmetrization of Prochiral Compounds 
 
 This variant of kinetic resolution is not limited by the same yield restraints. 
The symmetric substrates were able to be reacted under the optimized kinetic 
resolution conditions previously found. Prochiral diester 86 was converted to 
enantioenriched lactone 87 in high yield and selectivity. Prochiral diol 88 however 
was unsuccessful in forming enantioenriched lactone 89. Both lactones contain 
an all-carbon quaternary center that would be difficult to install otherwise. More 
detail on desymmetrizations can be found in the paper by Wilent and Petersen.7 
 The kinetic resolution developed was also able to be used on synthetically 
useful scales. The test substrate used in optimization was shown to have an 
isolated yield of recovered starting material of 34% and an enantiomeric excess 
of 93%. The α,α-disubstituted substrate was shown to have an isolated yield of 
38% and an enantiomeric excess of 94%.  
 The final item tested was the utilization of the enantiopure substrate 73a 
(figure 27). Enantiopure hydroxy ester 73a was transformed into lactone 74a 
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using trifluoroacetic acid in dichloromethane with a yield of 92% and no loss of 
ee. Substrate 73a was transformed into the amine ester 90 via pyridinium 
chlorochromate (PCC) oxidation, benzyl amine amination, and sodium 
triacetoxyborohydride reduction. Amino ester 90 was then transformed into the 
lactam 91 using trifluoroacetic acid at reflux. Both transformations afforded the 
product in decent yield with minimal loss of ee. 73a was reacted with PCC and 
then Oxone® to yield acid ester 92. 73a was also reacted with lithium aluminum 
hydride to reduce the ester and afford diol 93. This work was completed by 
Ghassan Qabaja. 
 
 
 
Figure 27. Enantioenriched Building Blocks 
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2.3 Conclusion 
 
 In summary, a facile, enantioselective synthesis of α-substituted γ-hydroxy 
tert-butyl esters via a Brønsted acid catalyzed kinetic resolution has been 
completed. This work has yielded optimized conditions for the kinetic resolution 
as well as two highly selective substrates. α-Methyl-γ-hydroxy tert-butyl ester has 
been shown to react to form at least five different compounds while the α-methyl-
α-phenyl γ-hydroxy tert-butyl ester has a quaternary center that is difficult to form. 
The optimized conditions from this work will be used in future endeavors as a 
starting place for other Brønsted acid catalyzed kinetic resolutions in the 
Petersen lab. 
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CHAPTER III 
 
DEVELOPMENT OF A BRØNSTED ACID CATALYZED KINETIC 
RESOLUTION OF γ-SUBSTITUTED, DISUBSTITUTED, AND CYCLIC 
HYDROXY ESTERS 
 
3.1 Background 
 
 Natural products extracted from animals and plants are found in 
enantiomerically pure form while the synthetic clones are usually prepared in a 
1:1 ratio of enantiomers. In some cases, one enantiomer is harmless while in 
others one enantiomer provides negative effects. However, even if one 
enantiomer is harmless, it constitutes waste and a potential pollutant. 
Consequently, enantiomerically pure compounds are of vital importance to the 
pharmaceutical fields and asymmetric synthesis of these drugs is a field that has 
been growing over the last few decades1. Single enantiomer pharmaceuticals 
made up 37% of the total pharmaceutical market sales in 20052. Between 2000 
and 2005, single enantiomer compounds annual growth rate increased by 11%.  
 As seen in chapter 2, kinetic resolutions are still a valid option in 
asymmetric synthesis. In chapter 3, kinetic resolution of small molecules with 
multiple stereocenters using a Brønsted acid catalyst is performed. 
Enantioenriched small building blocks with multiple substituents give the 
possibility of more handles to manipulate to look like natural products. 
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Particularly α,γ-disubstituted hydroxy compounds and γ-lactones have the 
potential to be used in the synthesis of complex macrolides such as the 
geodiamolide3 family and the amphidinolide4 family as well as the compound 
jaspamide5 (figure 28). Bicyclic precursors and lactones also have the potential 
to be used in natural product synthesis such as antifungals6 and GABA inhibitors7 
(figure 28). Cyclic hydroxy ester (–)-96 and bicyclic lactone (–)-97 have been 
used as building blocks for the angiotensine converting enzyme (ACE) inhibitor 
Trandolapril8 marketed by Abbott Laboratories.  
 
 
 
Figure 28. Natural Product Syntheses from Building Blocks with Multiple 
Stereocenters 
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3.2 Results and Discussion 
 
 
 
 
Figure 29. New Substrates 
 
 Previously, the Petersen group published an article in Organic Letters 
detailing the kinetic resolution of α-substituted γ-hydroxy tert-butyl esters9. With 
the optimized conditions determined, differently functionalized γ-hydroxy tert-
butyl esters were tested to increase the substrate scope of the previous results. 
The first to be tested were β- and γ-substituted γ-hydroxy tert-butyl esters. To 
form β-substituted substrate 98, methyl succinate anhydride was reacted with 
tert-butanol at 60 ˚C overnight (figure 29). The resulting reaction did not yield 
desired product so the temperature was increased to 85 ˚C. After a few hours 
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and no desired product, catalyst para-toluenesulfonic acid was added. This 
reaction was tried for an additional time with tert-butanol, dimethylaminopyridine 
(DMAP), pyridine, and dichloromethane. No desired product was recovered. 
Jakobsche and group previously showed that propionic acid can be reacted with 
tert-butyl bromoacetate to yield an ester/acid intermediate that could be reduced 
to the hydroxy ester (figure 30)10. In this experiment, however, very little desired 
product was obtained from this reaction. 
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Figure 30. Formation of β-Substituted Hydroxy Esters 
 
 γ-Substrates were developed concomitantly with the β-substrates. To form 
the desired γ-substrates (figure 31), succinic anhydride (116) was simultaneously 
opened and esterified using DMAP, N-hydroxysuccinimide, tert-butyl alcohol, and 
triethylamine (TEA) in toluene at reflux. The carboxylic acid portion of the 
resulting intermediate (117) was then reduced by BH3•THF and oxidized by 
pyridinium dichromate (PDC) to the aldehyde (119). Phenylmagnesium bromide  
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or methylmagnesium iodide was reacted with the aldehyde in a Grignard reaction 
to yield the appropriate γ-substituted hydroxy ester.  
 
 
Figure 31. Formation of γ-Substrates 
 
 
 These substrates were able to be produced in reasonable yields with 
enough material for initial experiments. Both γ-substrates had poor selectivity in 
the kinetic resolution using our standard conditions developed for α-substititued 
hydroxy esters (table 4).  
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Table 4. Lactonization of γ-Substrates 
 
Entry Substrate
Temp
( C)
Time
(h)
%conv %eesm %eep s
1
O
OH
O
5 24 68 25 2 1.6
2 O
OH
O
Ph
5 96 51 10 N/A 1.3
O
OH
O
R
O
OH
O
R
O
O
R
72 (2 mol %)
99
99 120
R = Me (99a)
R = Ph (99b)
+
 
  
 
 The next set of substrates tested was the disubstituted γ-hydroxy tert-butyl 
esters. α,γ-Dimethyl γ-hydroxy tert-butyl ester (figure 32) was formed from the 
reaction of tert-butyl propionate and propylene oxide. To do this, the propionate 
was first deprotonated at the α-carbon by lithium diisopropylamide (LDA) that 
was made in situ. Diethyl aluminum chloride and propylene oxide were then 
added to afford α,γ-dimethyl substrate 101a. 
 
 
 
Figure 32. Formation of α,γ-Dimethyl Substrate 
 
 
The α-methyl-γ-phenyl substrate was planned to be synthesized in the 
same fashion using styrene oxide. After the analogous reaction was completed, 
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analysis by NMR indicated that the phenyl ring was placed on the β-carbon 
(figure 33) due to the nucleophile attacking the secondary carbon forming 100a. 
α-Methyl-γ-phenyl γ-hydroxy tert-butyl ester 101b was then formed from 
commercially available 2-methyl-4-oxo-4-phenyl butyric acid (122). Acid 122 was 
esterified via Steglich esterification using DCC and DMAP. The ketone/ester 123 
was then reduced using sodium borohydride (NaBH4) to yield the hydroxy ester 
101b.  
 
 
 
Figure 33. Formation of α-Methyl-β-phenyl and α-Methyl-γ-phenyl 
Substrates  
 
 These disubstituted hydroxy esters underwent kinetic resolution as 
diastereomeric mixtures as it was difficult to separate the diastereomers by any 
means. The lactonization of the disubstituted hydroxy esters was executed in 
dichloromethane at the given temperature and time with catalyst 72. As seen in 
table 5, most lactonizations did not yield high selectivities of either product or 
recovered starting material. Substrate 101asyn was the only hydroxy ester in the 
set to show high selectivity.  
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Table 5. Results of the Kinetic Resolution of Disubstituted Hydroxy Esters 
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Peak 1 area Peak 2 area % ee
Syn Lactone 7.78319 18.95474 42
Anti Lactone 15.81304 12.93517 10
Anti Hydroxy
Ester
11.14236 8.98100 11
Syn Hydroxy
Ester
1.04258 23.34792 91
 
 
Figure 34. Chiral GC Chromatogram Displaying ee’s of Compound 100a 
 
 
 However, with 8 possible compounds, the conversion for lactonization 
needs to be calculated carefully. In this case, an internal standard was used for 
the lactonization of diastereomers. The internal standard, xylene, was chosen 
from a group of non-polar compounds by establishing the retention time on GC. 
A non-polar, non-reacting compound is needed so that there is no interference 
during lactonization. To perform the reaction, a stock solution of xylene in 
dichloromethane (226 mg in 500 mL) was prepared. The chosen substrate would 
101aanti
101asyn
anti lactone
syn lactone 
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then be dissolved in dichloromethane (10 mg in 10 mL) and 1 mL of the stock 
solution. An initial time point was taken before catalyst was added. This was 
done to determine the response factor, a number that accounts for differences in 
response between the analyte and internal standard.  
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Peak Name
Retention Time
(min)
Xylene 5.011
Syn Lactone 7.095
Anti Lactone 7.249
Anti Hydroxy Ester 9.628
Syn Hydroxy Ester 9.844
 
 
Figure 35. Chromatogram of t0 
 
 
The first calculation involves t0. This is to find the internal response factor 
(IRF).  
Starting 
Internal 
Product 
anti
antisyn
syn 
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 Where is = internal standard and s = substrate. The amounts must be 
exact and in mg form. The response factor is used to determine the amount of 
the substrate at t1 and on. In the case above, the area of the internal standard 
was 0.03660, the area of 101aanti was 0.01464, and the area of 101asyn was 
0.01488. The ratio of anti to syn was 0.98:1. The ratio needs to be considered to 
determine the amount of each isomer present in solution. An IRF is then 
calculated for each hydroxy ester. 
 
 
 
 
Figure 36. Chromatograms at t1 and t2 
 
  
 
t1 
t2 
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To determine the amount of substrate after t0: 
 
 
	  
 
  
 Again where is = internal standard, s = substrate, and IRF is the response 
factor previously found.  
 
Table 6. IRF Calculations 
 
 
 
 
Table 7. Conversion Calculations Based on IRF Values 
 
 
 
  
Due to the lack of separation of diastereomers and the fact that substrate 
101asyn was not formed in high diastereomeric excess, another method for this 
diastereoselective formation was explored. In the new method, 2-
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(bromomethyl)acrylic acid (125) was reacted with acetaldehyde and indium in 
tetrahydrofuran at room temperature (figure 37)11. The resulting lactone (127) 
was hydrogenated to yield α,γ-dimethyl lactone 128. The lactone was checked by 
achiral GC to determine if the syn configuration was the sole product. Upon 
determination, the lactone was opened through a reaction with first 
benzylbromide and potassium hydroxide in toluene then potassium hydroxide in 
methanol and water. The ether/acid 129 was then esterified with di-tert-butyl 
dicarbonate, N,N-dimethylaminopyridine, and tert-butyl alcohol in 
dichloromethane. The resulting ester 130 was deprotected through 
hydrogenolysis to remove the benzyl group and yield hydroxy ester 101asyn. 
 
 
 
Figure 37. Formation of Syn-α,γ-Dimethyl Hydroxy Ester  
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 Hydroxy ester 101asyn was lactonized on a large scale in dichloromethane 
at -5 ˚C with a catalyst load of 2 mol %. This reaction yielded 31% of 
enantioenriched hydroxy ester (99% ee, s = 15.7). The enriched hydroxy ester 
was lactonized with p-toluenesulfonic acid to yield enantioenriched lactone. 
Compared to literature values for optical rotation, the absolute configuration of 
the hydroxy ester was found to be R,S-α,γ-dimethyl hydroxy tert-butyl ester. 
 
 
Figure 38. Large Scale Lactonization of 100asyn 
 
  
  Ghassan Qabaja, a post-doc in the Petersen lab, has been working on the 
bicyclic precursors and lactones (substrates 103-110, figure 29). Dr. Qabaja is 
still currently working on this project. His current results are listed in table 8.  
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Table 8. Lactonization of Cyclic Hydroxy Esters 
 
Entry Substrate
Temp
( C)
Time (h) % conv %eesm %eep s
1
O
O
OH
Me 103a
-20 48 76 57 8 2.3
2
O
O
OH
Ph 103b
5 96 68 26 5 1.6
3 O
O
MeOH
104
RT 120 N/A 22 25 N/A
4 O
O
OH
105
-20 64 56 80 35 10.4
5 O
O
OH
106
0 20 60 95 33 15.7
6
OH
O
O
107
5 48 58 75 8 7.3
7
OH
O
O
108
-5 70 N/A 17 49 N/A
8
O
OH
O
O
109
-20 12 62 94 55 12.4
9
OH
O
O
110
-20 24 49 41 53 3.6
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3.3 Conclusion 
 
 In summary, the Brønsted acid catalyzed kinetic resolution of γ-substituted 
and disubstituted hydroxy esters has been shown. It was seen that most of the 
substrates were not enantioenriched under the current conditions. In the future, 
different Brønsted acid catalysts could be used to optimize these conditions and 
yield enantioenriched material. The cyclic hydroxy esters have shown more 
promising results; however, it is still in preliminary stages and the reactions need 
to be optimized before further experiments can be conducted.  
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CHAPTER IV 
 
EXPERIMENTAL 
 
 
4.1 General Information 
 
All anhydrous reactions were performed with dry solvents in oven dried 
glassware under an argon atmosphere.  Unless otherwise noted, all solvents and 
reagents were obtained from commercial sources and used without further 
purification. Purification via column chromatography was performed using silica 
gel (60 Å, 32-63 μm). NMR spectra were recorded using a JEOL ECA 
spectrometer (500 MHz for 1H, 125 MHz for 13C). Coupling constants, J, are 
reported in hertz (Hz) and multiplicities are listed as singlet (s), doublet (d), triplet 
(t), quartet (q), doublet of doublets (dd), triplet of triplets (tt), multiplet (m), etc. IR 
data was obtained with a Perkin Elmer FTIR spectrometer with frequencies 
reported in cm-1. High Resolution Mass Spectra were acquired on a 
ThermoFisher Scientific LTQ Orbitrap XL MS system.
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4.2 Benzyl Ether 76 
 
 
 
 
Figure 39. Benzyl Ether 76 
 
  
 Crushed KOH (3.0 g, 53.0 mmol) was added to a toluene (18 mL) solution 
of α-methyl-γ-butyrolactone (1.0 g, 10 mmol) and benzyl bromide (7.0 g, 40 
mmol). The reaction mixture was stirred at 110 ˚C for 5 h and then toluene was 
removed in vacuo. Next, methanol (20 mL) was added to reaction flask followed 
by crushed KOH (1.0 g, 17 mmol) and water (10 mL) then the reaction mixture 
was refluxed for 16 h. The reaction mixture was extracted with diethyl ether (3 x 
20 mL), the aqueous layer was acidified with concentrated HCl, and extracted 
with CH2Cl2 (3 x 20 mL). The combined organic extracts were dried over 
Mg2SO4, filtered, and concentrated in vacuo to give the product as a pale yellow 
oil (1.9 g, 92% yield). 
1H NMR (500 MHz, CDCl3) δ 7.24-7.40 (m, 5H), 4.50 (m, 2H), 3.52 (t, J=5 Hz, 
2H), 2.7 (m, 1H), 2.05 (m, 1H), 1.70 (m, 1H), 1.20 (d, J=5 Hz, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 182.50, 138.30, 128.47, 127.73, 127.70, 73.07, 
67.89, 36.53, 33.29, 17.10 ppm 
IR (neat) 3030, 2936, 2864, 1701, 1496, 1454, 1414, 1364, 1288, 1242, 1204, 
1094, 1026, 941 cm-1 
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HRMS (ESI) C12H16O3 [M+H]
+1, calculated 209.1133, found 209.1162 
 
4.3 Intermediate 77 
 
 
 
 
Figure 40. Intermediate 77 
 
 The carboxylic acid/ether (0.25 g, 1.2 mmol) was dissolved in isopropanol 
(0.75 mL, 9.8 mmol). Thionyl chloride (0.12 mL, 1.7 mmol) was added dropwise 
to the solution at room temperature. The reaction mixture was refluxed for 4 h. 
The solution was neutralized with NaHCO3 and extracted with diethyl ether (3 x 2 
mL). The combined organic layers were dried over Mg2SO4, filtered, and 
concentrated in vacuo. Flash chromatography on silica gel (10% EtOAc in 
hexanes) afforded the intermediate ester/benzyl ether as a colorless oil (234 mg, 
78% yield). 
1H NMR (500 MHz, CDCl3) δ 7.32 (m, 5H), 4.98 (m, 1H), 4.48 (s, 2H), 3.48 (m, 
2H), 2.58 (m, 1H), 2.00 (m, 1H), 1.70 (m, 1H), 1.20 (d, J = 5.16 Hz, 3H), 1.19 (d, 
J = 4.58, 3H), 1.14 (d, J=6.87 Hz, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 176.13, 138.81, 128.65, 127.94, 127.65, 72.93, 
67.85, 67.15, 36.31, 33.16, 21.94, 17.38 ppm 
IR (neat) 2979, 2361, 1725, 1454, 1373, 1179, 1104, 734, 696, 507 cm-1 
HRMS (ESI) C15H22O3 [M+H]
+1, calculated 251.1672, found 251.1637 
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4.4 Hydroxy Isopropyl Ester 73b 
 
 
 
 
Figure 41. Hydroxy Isopropyl Ester 73b 
 
 
 To the above intermediate (0.204 g, 1.3 mmol) in EtOAc (8 mL) was 
added Pd(OH)2/C (0.02 g, 10% by weight of intermediate). The reaction flask was 
flushed of all gases then a balloon of H2 was added to the flask. The reaction 
stirred overnight at room temperature. The mixture was filtered through a plug of 
Celite® and the filtrate was concentrated. The concentrated filtrate was purified 
using flash chromatography on silica gel (15% acetone in CH2Cl2). The 
fractions were check by GC to detect product. No yield was obtained on this 
compound. 
1H NMR (500 MHz, CDCl3) δ 5.01 (m, 1H), 3.68 (td, J=6.16, 4.87 Hz, 2H), 2.59 
(dd, J=8.31, 1.43 Hz, 1H) 1.91 (m, 1H), 1.69 (m, 1H), 1.23 (d, J = 2.86, 3H), 1.21 
(d, J = 2.86, 3H), 1.19 (m, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 176.54, 67.78, 60.80, 36.81, 36.38, 21.87, 17.29 
ppm 
IR (neat) 3416, 2979, 2361, 1725, 1456, 1374, 1176, 1121, 1049, 519, 509 cm-1 
HRMS (ESI) C8H16O3 [M+H]
+1, calculated 161.1172, found 161.1167 
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4.5 Intermediate 85 
 
 
 
 
Figure 42. Intermediate 85 
 
 
 DCC (1.25 g, 6 mmol) was added to a mixture of the carboxylic acid/ether 
(1.04 g, 5.0 mmol), DMAP (0.125 g, 1 mmol), 2,4-dimethyl-3-pentanol (21 mL, 15 
mmol), and CH2Cl2 (50 mL) at room temperature. The reaction mixture was 
stirred at -10 ˚C for 24 h. The mixture was diluted with hexanes (50 mL), filtered, 
and concentrated in vacuo. Flash chromatography on silica gel (5% EtOAc in 
hexanes) afforded the intermediate as a clear and colorless oil (1.35 g, 76% 
yield). 
1H NMR (500 MHz, CDCl3) δ 7.31 (m, 5H), 4.59 (m, 1H), 4.48 (m, 2H), 3.51 (qt, 
J= 9,69, 6.37 Hz, 2H), 2.69 (m, 1H), 2.07 (m, 1H), 1.88 (qd, J= 6.68, 5.16 Hz, 
2H), 1.70 (m, 1H), 1.20 (d, J= 7.45 Hz, 3H) 0.85 (m, 12H) ppm 
13C NMR (126 MHz, CDCl3) δ 176.54, 138.47, 128.48, 127.80, 127.68, 82.30, 
73.12, 68.14, 36.93, 33.54, 29.49, 19.71, 17.38 ppm 
IR (neat) 2968, 2360, 1727, 1454, 1368, 1177, 1096, 950, 733, 696, 506 cm-1 
HRMS (ESI) C19H30O3 [M+H]
+1, calculated 307.2272, found 307.2257 
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4.6 Hydroxy Dimethylpentyl Ester 73c 
 
 
 
 
Figure 43. Hydroxy Dimethylpentyl Ester 73c 
 
 
 To the above intermediate (1.35 g, 4.41 mmol) in EtOAc (45 mL) was 
added Pd(OH)2/C (0.14 g, 10% by weight of intermediate) was added. The 
reaction flask was flushed of all gases and then a balloon of H2 was added to the 
flask. The reaction was stirred overnight at room temperature. The mixture was 
filtered through a pad of Celite ® and concentrated in vacuo to afford compound 
as a colorless oil (0.97 g, >99% yield) 
1H NMR (500 MHz, CDCl3) δ 4.59 (t, J= 6.01 Hz, 1H), 3.69 (td, J=6.30, 2.29 Hz, 
2H), 2.67 (dt, J= 7.88, 6.66 Hz, 1H), 1.97 (m, 1H), 1.89 (ddd, J= 13.17, 6.59, 3.72 
Hz, 2H) 1.69 (m, 1H), 1.23 (m, 3H), 0.86 (m, 12H) ppm 
13C NMR (126 MHz, CDCl3) δ 176.93, 82.64, 60.85, 37.07, 36.30, 29.46, 19.67, 
17.40 ppm 
IR (neat) 3447, 2969, 2360, 1728, 1462, 1387, 1252, 1172, 1129, 1104, 999, 
964, 945, 813, 512 cm-1 
HRMS (ESI) C12H24O3 [M+H]
+1, calculated 217.1772, found 217.1792 
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4.7 4-(Tert-butoxy)-4-oxobutanoic Acid 117 
 
 
 
 
Figure 44. 4-(Tert-butoxy)-4-oxobutanoic Acid 117 
 
 Succinic anhydride (5 g, 50 mmol), N-hydroxysuccinimide (1.73 g, 15 
mmol), and DMAP (1.83 g, 15 mmol) were dissolved in toluene (25 mL) at rt. t-
Butanol (6.22 mL, 65 mmol) and triethylamine (2.09 mL, 15 mmol) were added to 
the mixture and the reaction was heated at reflux overnight. The reaction mixture 
was then washed with 10% citric acid (2 x 20 mL) and brine (2 x 20 mL). The 
organic layer was dried over Mg2SO4, filtered, and concentrated in vacuo yielding 
pure yellow oil (4.673 g, 54%). 
1H NMR (500 MHz, CDCl3) δ 2.61 (d, J = 6.87 Hz, 2H), 2.53 (d, J = 6.87 Hz, 2H), 
1.44 (m, 9H) ppm 
13C NMR (126 MHz, CDCl3) δ 178.11, 171.51, 81.12, 30.14, 29.16, 28.09 ppm 
 IR (neat) 1787, 1712, 1366, 1146, 1069, 845 cm-1  
HRMS (C8H14O3, ESI) [M-H]
-, calculated 173.1827, found 173.0811 
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4.8 Tert-butyl 4-Hydroxybutanoate 118 
 
 
 
 
Figure 45.  Tert-butyl 4-Hydroxybutanoate 118 
 
 
 To a solution of 4-(tert-butoxy)-4-oxobutanoic acid (4.673 g, 27 mmol) in 
dry THF (45 mL) was added BH3•THF (1M, 30 mL, 30 mmol) dropwise at 0 ˚C. 
The reaction mixture was stirred overnight at rt. The reaction was cooled to 0 ˚C. 
DI water (30 mL) and solid K2CO3 were added to the reaction mixture. The 
mixture was then extracted with Et2O (3 x 30 mL). The combined organic layers 
were washed with brine (1 x 30 mL), dried over Mg2SO4, filtered, and 
concentrated in vacuo yielding pure yellow oil (3.705 g, 86%). 
1H NMR (500 MHz, CDCl3) δ 3.56 (m, 2H), 3.44 (m, 2H), 2.15 (m, 2H), 1.27 (m, 
9H) ppm 
13C NMR (126 MHz, CDCl3) δ 25.67, 28.13, 32.49, 62.19, 80.64, 173.62 ppm 
 IR (neat) 3384, 2976, 2932, 1726, 1366, 1249, 1147, 1056, 844 cm-1  
HRMS (ESI) C8H14O3 [M+H-C4H8]
+ calculated 105.1073, found 105.0549 
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4.9 Tert-butyl 4-Oxobutanoate 119 
 
 
 
 
Figure 46. Tert-butyl 4-Oxobutanoate 119 
 
 
 A flame-dried round bottom flask was flushed with argon. Pyridinium 
dichromate (5.267 g, 14 mmol) and celite (5.267 g) were then placed in the flask, 
air was evacuated and argon was flushed in. CHCl2 (80 mL) was added to the 
system and then tert-butyl 4-hydroxybutanoate (1.73 g, 10.8 mmol) dissolved in 
CHCl2 (20 mL) was added to the flask. The reaction mixture stirred at rt 
overnight. The mixture was then filtered through celite and concentrated in 
vacuo. Purification was done via column chromatography (1.5” x 7” silica gel, 
20% Et2O in pet. ether) which yielded 1.341 g of yellow oil product (79%).  
1H NMR (500 MHz, CDCl3) δ 9.79 (s, 1H), 2.72 (m, 2H), 2.54 (m, 2H), 1.43 (s, 
9H) ppm 
13C NMR (126 MHz, CDCl3) δ 200.55, 171.61, 81.02, 38.81, 28.11, 27.94 ppm 
 IR (neat) 2978, 2935, 2828, 2729, 1721, 1366, 1241, 1148, 844 cm-1  
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4.10 Tert-butyl 4-Hydroxypentanoate 99a 
 
 
 
 
Figure 47. Tert-butyl 4-Hydroxypentanoate 99a 
 
 
 119 (0.095 g, 0.6 mmol) in THF (4 mL) was placed in a flame-dried round 
bottom flask under argon at -78 ˚C. Methylmagnesium bromide (3M in THF, 0.23 
mL, 0.7 mmol) was added dropwise and the reaction mixture stirred at -78 ˚C for 
5 hours. The reaction was quenched with NH4Cl, extracted with EtOAc, dried, 
and concentrated in vacuo. Purification was done by column chromatography 
(0.5” x 5.5” silica gel, 20% EtOAc in Hexanes) yielding 0.048 g of yellow oil 
product (46%).  
1H NMR (500 MHz, CDCl3) δ 3.81 (m, 1H), 2.34 (t, J = 7.16 Hz, 2H), 1.71 (m, 
2H), 1.43 (s, 9H), 1.19 (d, J = 6.30 Hz, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 173.72, 80.58, 67.57, 34.05, 23.59, 32.16, 28.15 
ppm 
IR (neat) 3424, 2967, 2931, 1729, 1456, 1366, 1256, 1150, 1079, 943, 845 cm-1 
HRMS (ESI): C9H18O3 [M+H]
+1, calculated 175.2473, found 175.0759  
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4.11 Tert-butyl 4-Hydroxy-4-(4-methoxyphenyl)butanoate 99b 
 
 
 
 
Figure 48. Tert-butyl 4-Hydroxy-4-(4-methoxyphenyl)butanoate 99b 
 
 
 119 (0.569 g, 3.6 mmol) in THF (24 mL) was placed in a flame-dried round 
bottom flask under argon at -78 ˚C. P-methoxyphenylmagnesium bromide (0.5M 
in THF, 8.6 mL, 4.3 mmol) was added dropwise and the reaction mixture stirred 
at -78 ˚C for 3 hours. The reaction was quenched with NH4Cl, extracted with 
EtOAc, dried and concentrated in vacuo. Purification was done by column 
chromatography (1” x 7” silica gel, 10-20% EtOAc in Hexanes) yielded 0.431 g of 
colorless liquid product (45%).  
1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 
4.69 (m, 1H), 3.80 (s, 3H), 2.30 (m, 2H), 2.01 (m, 2H), 1.44 (s, 9H) ppm 
13C NMR (126 MHz, CDCl3) δ 173.45, 159.12, 136.44, 127.10, 113.92, 80.60, 
73.43, 55.38, 34.03, 32.11, 28.18 ppm 
IR (neat) 3438, 2976, 2932, 2836, 1723, 1611, 1585, 1511, 1456, 1366, 1243, 
1145, 1033, 830, 752 cm-1 
HRMS (ESI) C15H22O4 [M+Na]
+1, calculated 289.3191, found 289.1411 
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4.12 Tert-butyl 4-Hydroxy-2-methyl-3-phenylbutanoate 100a 
 
 
 
 
Figure 49. Tert-butyl 4-Hydroxy-2-methyl-3-phenylbutanoate 100a 
 Lithium diisopropylamide was prepared in situ by dissolving distilled 
diisopropylamine (1.6 mL, 11.4 mmol) in dry THF (15 mL) in a flame-dried flask 
under argon at -78 ˚C. n-Butyllithium (1.6 M in hexanes, 7.1 mL, 11.4 mmol) was 
added dropwise and the mixture was stirred for 15 min at -78 ˚C. Tert-butyl 
propionate (1.1mL, 7.6 mmol) was then added dropwise and the mixture was 
stirred for 15 min at -78 ˚C. Diethylaluminum chloride (1M in hexanes, 7.6 mL, 
7.6 mmol) was added dropwise and the mixture was stirred for 15 min at -78 ˚C. 
Styrene oxide (0.43 mL, 3.8 mmol) was added dropwise and the mixture was 
stirred for 2 hours at -78 ˚C. The reaction was quenched with NH4Cl and added 
to a beaker with 4M HCl (20 mL) and ice (10 g). After the ice had melted, the 
aqueous mixture was extracted twice with ether and the organic layer was 
washed twice with 5% NaHCO3, once with brined, dried, and concentrated in 
vacuo. Purification was done by column chromatography (1” x 9” silica gel, 10-
20% EtOAc in hexanes) to yield 0.400 g colorless oil mixture of diastereomers 
(42%, dr 1.2:1). 
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anti: 1H NMR (500 MHz, CDCl3) δ 7.39 (m, 1H), 7.33 (m, 2H), 7.22 (m, 2H), 3.80 
(m, 2H), 2.99 (m, 1H), 2.65 (dd, J = 10.31, 6.87 Hz, 1H), 1.49 (s, 9H), 0.93 (d, J = 
6.87 Hz, 3H) 
13C NMR (126 MHz, CDCl3) δ 175.78, 140.08, 128.81, 128.69, 127.21, 80.84, 
65.91, 51.67, 43.16, 28.21, 16.33 
IR (neat) 3423, 2976, 2932, 1722, 1454, 1367, 1246, 1148, 1065, 846, 698 cm-1 
syn: 1H NMR (500 MHz, CDCl3) δ 7.30 (m, 2H), 7.23 (m, 3H), 3.91 (m, 1H), 3.82 
(m, 1H), 2.98 (m, 1H), 2.79 (m, 1H), 1.23 (d, J = 6.87 Hz, 3H), 1.18 (s, 9H) 
13C NMR (126 MHz, CDCl3) δ 174.15, 140.58, 128.77, 128.57, 127.18, 80.29, 
64.43, 51.26, 42.83, 27.74, 15.59 
IR (neat) 3422, 2979, 2938, 1712, 1456, 1368, 1153, 848 cm-1 
 
4.13 Tert-butyl 4-Hydroxy-2-methylpentanoate 101a 
 
 
 
 
Figure 50. Tert-butyl 4-Hydroxy-2-methylpentanoate 101a 
 
 Lithium diisopropylamide was prepared in situ by dissolving distilled 
diisopropylamine (1.6 mL, 11.4 mmol) in dry THF (15 mL) in a flame-dried flask 
under argon at -78 ˚C. n-Butyllithium (1.6 M in hexanes, 7.1 mL, 11.4 mmol) was 
added dropwise and the mixture was stirred for 15 min at -78 ˚C. Tert-butyl 
propionate (1.1 mL, 7.6 mmol) was then added dropwise and the mixture was 
71 
 
stirred for 15 min at -78 ˚C. Diethylaluminum chloride (1M in hexanes, 7.6 mL, 
7.6 mmol) was added dropwise and the mixture was stirred for 15 min at -78 ˚C. 
Propylene oxide (0.27 mL, 3.8 mmol) was added dropwise and the mixture was 
stirred for 2 hours at -78 ˚C. The reaction was quenched with NH4Cl and added 
to a beaker with 4M HCl (20 mL) and ice (10 g). After the ice had melted, the 
aqueous mixture was extracted twice with ether and the organic layer was 
washed twice with 5% NaHCO3, once with brined, dried, and concentrated in 
vacuo. Purification was done by column chromatography (1” x 9” silica gel, 10-
20% EtOAc in hexanes) to yield 0.887 g colorless oil mixture of diastereomers 
(62%, dr 2.7:1).  
anti: 1H NMR (500 MHz, CDCl3) δ 3.79 (m, 1H), 2.54 (m, 1H), 1.68 (d, J = 3.66 
Hz, 1H), 1.46 (dd, J = 9.16, 4.58 Hz, 1H), 1.40 (s, 9H), 1.14 (d, J = 6.41, 3H), 
1.09 (d, J = 6.87 Hz, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 176.52, 80.48, 65.80, 43.18, 37.34, 28.10, 23.69, 
17.86 ppm 
IR (neat) 3386, 2973, 2934, 1708, 1457, 1367, 1255, 1148, 1081, 1035, 848 cm-1 
HRMS (ESI) C10H20O3 [M+Na]
+1, calculated 211.129, found 211.130.  
syn: 1H NMR (500 MHz, CDCl3) δ 3.83 (m, 1H), 2.56 (m, 1H), 1.72 (m, 1H), 1.48 
(m, 1H), 1.43 (s, 9H), 1.17 (d, J = 5.95, 3H), 1.12 (d, J = 7.33, 3H)  
13C NMR (126 MHz, CDCl3) δ 176.46, 80.54, 65.91, 43.20, 37.32, 28.15, 23.71, 
17.84 ppm 
IR (neat) 3389, 2976, 1710, 1455, 1359, 1255, 1144, 1029, 850 cm-1 
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HRMS (ESI) C10H20O3 [2M+Na]
+1, calculated 399.2701, found 399.1771 
 
4.14 Tert-butyl 2-Methyl-4-oxo-4-phenylbutanoate 123 
 
 
 
 
Figure 51. Tert-butyl 2-Methyl-4-oxo-4-phenylbutanoate 123 
 
 Commercially available 2-methyl-4-oxo-4-phenylbutanoic acid (0.903 g, 
4.7 mmol) was esterified with t-butanol (1.3 mL, 14 mmol), DCC (1.16 g, 5.6 
mmol), and DMAP (0.114 g, 0.93 mmol) in CHCl2 (23 mL). All reagents were 
placed in a flame-dried flask under argon and stirred for 4 hours at -5 ˚C. The 
mixture was quenched with hexanes and filtered. The filtrate was concentrated in 
vacuo and purified via column chromatography (1.5” x 6” silica gel, 10-20% 
EtOAc in hexanes). 0.441 g of white solid product was obtained (62%).  
1H NMR (500 MHz, CDCl3) δ 7.95 (m, 2H), 7.55 (m, 1H), 7.45 (m, 2H), 3.43 (m, 
1H), 3.00 (m, 2H), 1.42 (s, 9H), 1.23 (d, J = 7.33 Hz, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 198.38, 175.34, 136.92, 133.16, 128.65, 128.11, 
80.39, 42.02, 36.03, 28.08, 17.49 ppm 
IR (neat) 2967, 2933, 1728, 1674, 1596, 1447, 1365, 1218, 1150, 1004, 852, 
763, 691 cm-1 
HRMS (ESI) C15H20O3 [M + Na]
+1, calculated 271.2921, found 271.1301 
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4.15 Tert-butyl 4-Hydroxy-2-methyl-4-phenylbutanoate 101b 
  
 
 
 
Figure 52. Tert-butyl 4-Hydroxy-2-methyl-4-phenylbutanoate 101b 
 
 The ketone was then reduced by dissolving sodium borohydride (0.269 g, 
7.1 mmol) in dry methanol (6 mL) in a flame-dried round bottom under argon in 
an ice bath. The ketone (0.447 g, 1.8 mmol) in dry methanol (2 mL) was then 
added dropwise at 0 ˚C. The reaction was allowed to warm up over one hour 
then was quenched with 1M HCl (ph ~2). The methanol was removed in vacuo 
and the aqueous layer was extracted with CHCl2 (3 x 5 mL). The combined 
organic layers were dried and concentrated in vacuo. Purification was done via 
column chromatography (1” x 7” silica gel, 20% EtOAC in hexanes) to yield 0.289 
g colorless oil mixture of diastereomers (65%, dr 1.5:1).  
anti: 1H NMR (500 MHz, CDCl3) δ 7.33 (m, 5H), 4.68 (m, 1H), 2.59 (m, 1H), 2.44 
(m, 1H), 2.16 (m, 1H), 1.44 (s, 9H), 1.15 (d, J = 3.44, 3H) 
13C NMR (126 MHz, CDCl3) δ 176.54, 144.71, 128.55, 127.67, 125.96, 80.40, 
72.88, 43.02, 38.06, 28.13, 17.70 
IR (neat) 3427, 2975, 2934, 1724, 1455, 1366, 1149, 1028, 846, 699 cm-1 
syn: 1H NMR (500 MHz, CDCl3) δ 7.25 (m, 5H), 4.75 (m, 1H), 2.02 (m, 1H), 1.78 
(m, 1H), 1.66 (m, 1H), 1.46 (s, 9H), 1.14 (d, J = 3.44, 3H) 
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13C NMR (126 MHz, CDCl3) δ 28.17, 32.10, 34.03, 55.38, 73.41, 80.60, 113.91, 
127.09, 136.44, 159.11, 173.45 ppm 
IR (neat) 3429, 2975, 2934, 1723, 1454, 1366, 1149, 1028, 698 cm-1 
 
4.16 Lactone 127 
 
 
 
 
Figure 53. Lactone 127 
 
 2-(Bromomethyl)acrylic acid (0.5 g, 3 mmol) was dissolved in THF:H2O 
(1:3, 0.75 mL: 2.25 mL). Indium metal (0.34 g, 3 mmol) and acetaldehyde (0.17 
mL, 3 mmol) were added and the reaction mixture was stirred at rt for 1 h. 6M 
HCl (2.3 mL, 68 mmol) was added to the reaction and the mixture was stirred at 
rt overnight. The reaction was extracted with EtOAc (3 x 10 mL). The organic 
layer was dried over Mg2SO4, filtered, and concentrated in vacuo yielding yellow 
oil (0.254 g, 76%) 
1H NMR (500 MHz, CDCl3) δ 6.20 (t, J = 2.86, 1H), 5.61 (t, J = 2.58, 1H), 4.65 
(dt, J = 7.45, 6.30, 1H), 3.07 (m, 1H), 2.52 (m, 1H), 1.40 (d, J = 6.30 Hz, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 170.47, 134.93, 122.22, 74.07, 35.24, 22.09 ppm 
 IR (neat) 1755, 1665, 1386, 1256, 1084, 1036, 951, 813 cm-1  
HRMS (C8H14O3, ESI) [M+H]
+, calculated 113.1373, found 113.0601 
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4.17 Lactone 128 
 
 
 
 
Figure 54. Lactone 128 
 
 To lactone 127 (0.254 g, 2.27 mmol) in EtOAc (23 mL) was added 
Pd(OH)2/C (0.025 g, 10% by weight of intermediate) was added. The reaction 
flask was flushed of all gases and then a balloon of H2 was added to the flask. 
The reaction was stirred overnight at room temperature. The mixture was filtered 
through a pad of Celite ® and concentrated in vacuo to afford compound 128 as 
a colorless oil (0.258 g, >99%) 
1H NMR (500 MHz, CDCl3) δ 4.45 (dt, J  = 10.76, 5.61 Hz, 1H), 2.66 (m, 1H), 
2.49 (m, 1H), 1.47 (m, 1H), 1.39 (d, J  = 6.41, 3H), 1.25 (d, J = 6.87, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 179.80, 75.06, 39.17, 36.49, 21.00, 15.19 ppm 
 IR (neat) 1768, 1736, 1373, 1239, 1177, 1042, 950 cm-1  
HRMS (ESI) C8H14O3 [M+H]
+ calculated 115.1428, found 115.0756 
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4.18 Ether 129 
 
 
 
 
Figure 55. Ether 129 
 
 Crushed KOH (0.685 g, 12.2 mmol) was added to a toluene (10 mL) 
solution of lactone 128 (0.258 g, 2.3 mmol) and benzyl bromide (1.1 mL, 9.2 
mmol). The reaction mixture was stirred at 110 ˚C for 5 h and then toluene was 
removed in vacuo. Next, methanol (10 mL) was added to reaction flask followed 
by crushed KOH (0.219 g, 3.9 mmol) and water (5 mL) then the reaction mixture 
was refluxed for 16 h. The reaction mixture was extracted with diethyl ether (3 x 
10 mL), the aqueous layer was acidified with concentrated HCl, and extracted 
with CH2Cl2 (3 x 10 mL). The combined organic extracts were dried over 
Mg2SO4, filtered, and concentrated in vacuo to give the product as a pale yellow 
oil (0.276 g, 54%). 
1H NMR (500 MHz, CDCl3) δ 7.31 (m, 5H), 4.40 (s, 2H), 3.58 (m, 1H), 2.63 (m, 
1H), 1.44 (m, 2H), 1.22 (d, J = 5.95, 3H), 1.13 (d, J = 7.33, 3H) ppm 
13C NMR (126 MHz, CDCl3) δ 182.96, 138.54, 128.44, 127.86, 127.63, 72.69, 
70.39, 40.55, 36.61, 19.65, 17.21 ppm 
 IR (neat) 3030, 2972, 2935, 1703, 1454, 1287, 1091, 950, 735, 697 cm-1  
HRMS (ESI) C8H14O3 [M-H]
- calculated 221.2727, found 221.1178 
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4.19 Protected Ester 130 
 
 
 
 
Figure 56. Protected Ester 130 
 
 To a solution of ether intermediate 1129 (0.276 g, 1.2 mmol), DMAP 
(0.146 g, 1.2 mmol), and t-butanol (0.33 mL, 3.6 mmol) in CH2Cl2 was added boc 
anhydride (0.262 g, 1.2 mmol). The reaction mixture was stirred at rt overnight. 
The solvent was then removed in vacuo. Column chromatography (1” x 5” silica 
gel, 0-10% EtOAc in Hexanes) afforded product (0.150 g, 45%). 
 
4.20 Synthesis of 101asyn 
 
 
 
 
Figure 57. Synthesis of 101asyn 
 
 To intermediate 130 (0.150 g, 0.5 mmol) in EtOAc (5 mL) was added 
Pd(OH)2/C (0.015 g, 10% by weight of intermediate) was added. The reaction 
flask was flushed of all gases and then a balloon of H2 was added to the flask. 
The reaction was stirred overnight at room temperature. The mixture was filtered 
through a pad of Celite ® and concentrated in vacuo to afford compound as a 
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colorless oil (0.083 g, 89%). The analytical data for this compound can be found 
under compound 101a. 
 
4.21 Large Scale Lactonization of 101asyn 
 
 
 
Figure 58. Large Scale Lactonization of 101asyn 
 
 Hydroxy ester 101asyn (278 mg, 1.25 mmol) was dissolved in CH2Cl2 (50 
mL) and catalyst 72 (18.8 mg, 0.025 mmol) was added to the reaction mixture. 
The mixture was stirred for 48 hours and quenched with EtOAc. Solvent was 
removed in vacuo and the crude mixture was purified via column 
chromatography (0.5” x 4” silica gel, 0-10% EtOAc/Hexanes) yielding a light 
yellow oil (31%, 99% ee). Enantioenriched hydroxy ester (10 mg, 0.05 mmol) 
was dissolved in CH2Cl2 (5 mL) and p-toluenesulfonic acid (0.02 mg, 0.001 
mmol) was added. The yielded lactone was then used to determine absolute 
configuration.  
4.22 General Procedure for Lactonization on GC Scale 
 To an oven dried screw-caped vial was introduced anhydrous solvent (10 
mL), and hydroxyester (10 mg, 0.057 mmol). To the vial was added 1 mL of 
internal standard (226 mg xylene in 500 mL CH2Cl2). The vial was conditioned to 
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the experiment temperature for 10 min and an initial time point was taken, after 
which catalyst (1.0 mg, 0.0013 mmol) was added and the reaction mixture was 
aged at experiment temperature. Aliquots were taken for chiral GC analysis. 
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APPENDIX A 
 
NMR SPECTRA OF COMPOUNDS 
 
 
NMR spectra were recorded using a JEOL ECA spectrometer (500 MHz 
for 1H, 125 MHz for 13C). All spectra were taken at room temperature in 
deuterated chloroform unless otherwise noted. 
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APPENDIX B 
 
CHROMATOGRAMS 
 
 
 GC Chromatograms were obtained from an Agilent 7890A. The chiral 
column used was a Supelco Betadex 110. HPLC chromatograms were obtained 
from an Agilent 1260 infinity. The chiral column used was a Chiralcel OJ-H. Flow 
rates and times can be found with chromatograms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98
Substrate 99a 
O
O
OH
99aanti  
GC Conditions: Column: 190916-13213, 30m x 320 μm x 0.25 μm; Eluent Rate: 
3 mL/min; Temperature Ramp: 50 ˚C for 30 min, ramp 2 ˚C/min  170 ˚C, 170 
˚C for 10 min 
Racemic 
 
 
 
 
 
99
Enantiomeric 
 
 
Substrate 99b 
O
O
OH
99banti
Ph
 
GC Conditions: Acetal derivative where H is replaced with Ac; Column: 190916-
13213, 30m x 320 μm x 0.25 μm; Eluent Rate: 3 mL/min; Temperature Ramp: 
100 ˚C for 60 min, ramp 2 ˚C/min  120 ˚C, 120 ˚C for 60 min, ramp 2 ˚C/min  
140 ˚C, 140 ˚C for 60 min, ramp 2 ˚C/min  170 ˚C, 170 ˚C for 60 min 
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Racemic 
 
 
Enantiomeric 
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Substrate 101a 
O
O
OH
101aanti
+
O
O
OH
101asyn  
GC Conditions: Column: 190916-13213, 30m x 320 μm x 0.25 μm; Eluent Rate: 
3 mL/min; Temperature Ramp: 70 ˚C for 60 min, ramp 5 ˚C/min  170 ˚C, 170 
˚C for 10 min 
Racemic 
 
101aanti  
101asyn  
102
Enantiomeric 
 
101aanti  
101asyn  
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Large Scale Chromatogram 
 
 
Substrate 101b 
O
O
OH
Ph
101banti
+
O
O
OH
Ph
101bsyn  
GC Conditions: Column: 190916-13213, 30m x 320 μm x 0.25 μm; Eluent Rate: 
3 mL/min; Temperature Ramp: 120 ˚C for 60 min, ramp 5 ˚C/min  170 ˚C, 170 
˚C for 60 min 
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Racemic 
 
101banti  
101banti  
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Enantiomeric 
 
101banti  
101bsyn  
 
Substrate 100a 
O
O
OH
101banti
+
O
O
OH
101bsyn
Ph Ph
 
HPLC Conditions: Column: OJ-H, 30m x 320 μm x 0.25 μm; Eluent Rate: 1 
mL/min; Eluent Percentage: 5 % Isopropyl Alcohol, 95% Hexanes; Time: 30 min 
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Racemic 
 
 
100aanti – 1&2, 100asyn – 3&4 
Enantiomeric 
 
 
100aanti – 1&2, 100asyn – 3&4 
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